ProCE Banner Activity

Practical Guidance for the Multidisciplinary Team on Therapeutics Targeting Protein Degradation Pathways in NHL

Slideset

Downloadable slideset on the rationale for targeting protein degradation pathways in NHL and the available efficacy and safety data with CELMoDs in NHL.

Released: September 13, 2024

Expiration: September 12, 2025

Share

Faculty

Ian Flinn

Ian Flinn, MD, PhD

Chief Scientific Officer
OneOncology
Nashville, Tennessee

Brad Kahl

Brad Kahl, MD

Professor of Medicine
Washington University in St Louis
Director, Lymphoma Program
Siteman Cancer Center
St Louis, Missouri

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by an educational grant from Bristol Myers Squibb.

Bristol Myers Squibb